Neumora Therapeutics, Inc. (NMRA) financials · $283.5M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Neumora Therapeutics, Inc. (NMRA) $283.5M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$241.2M | -$263.5M |
| Net Income | -$236.9M | -$243.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $191.0M | $317.0M |
| Current Assets | $190.5M | $314.1M |
| Cash & Equivalents | $182.5M | $142.1M |
| PP&E | $40.0K | $1.14M |
| Total Liabilities | $87.2M | $29.9M |
| Current Liabilities | $32.5M | $29.9M |
| Short-term Debt | $60.0M | N/A |
| Long-term Debt | $54.5M | N/A |
| Total Debt | $114.5M† | N/A |
| Shareholders' Equity | $103.9M | $287.1M |
| Retained Earnings | -$1.18B | -$947.2M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$206.4M | -$182.9M |
| Investing Cash Flow | $168.5M | -$70.6M |
| Financing Cash Flow | $77.1M | $21.6M |
| Net Change in Cash | $39.2M | -$231.9M |
FAQ
What is NMRA P/E and revenue?
Neumora Therapeutics, Inc. (NMRA) $283.5M cap.
What is NMRA revenue?
NMRA income-statement cache has no revenue figure yet.
Is NMRA profitable?
Neumora Therapeutics, Inc. last cached net income is -$236.9M (FY2025).
What are NMRA total assets?
Neumora Therapeutics, Inc. last cached total assets are $191.0M (FY2025).
What is NMRA free cash flow?
No cached cash-flow row for NMRA yet.
Not investment advice. Cached statements, not a live tape.